Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Diagnostic Microbiology and Infectious Disease|December 24, 1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococciC R Messick, S L Pendland
The Journal of Antimicrobial Chemotherapy|August 1, 1998
Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophilaS J Martin, S L Pendland
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 15, 1995
Bacterial resistance to beta-lactam antibioticsL H Danziger, S L Pendland
Diagnostic Microbiology and Infectious Disease|November 21, 1998
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococciC R Messick, J Woodward, S L Pendland
In Vivo (Athens, Greece)|February 5, 2004
Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pyloriS Bhamarapravati, S L Pendland, G B Mahady
The Annals of Pharmacotherapy|October 26, 2001
Antimicrobial-coated/bonded and -impregnated intravascular cathetersM P Pai, S L Pendland, L H Danziger
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinationsC R Messick, K A Rodvold, S L Pendland
Antimicrobial Agents and Chemotherapy|July 1, 1997
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pyloriJ M Meyer, S Ryu, S L Pendland, et al.
Anticancer Research|January 30, 2003
Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogenG B Mahady, S L Pendland, G Yun, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1997
In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella sppS L Pendland, A D Killian, J G Woodward, et al.
Pageof 3